LONDON: MGC Pharmaceuticals Ltd announced the acquisition of 100% of the issued share capital of MediCaNL Inc. MediCaNL Inc is the holding company of MediCaNL Israel 2019 Ltd, an Israeli company operating in and providing specialist services to the pharmaceutical sector for development of new medicines. MediCaNL offers clinical and preclinical trial services, as well…
LONDON: The first UK clinical trials of a nasal spray proven to kill 99.9% of the coronavirus that causes Covid-19 will begin on January 11th at Ashford and St Peter’s Hospitals NHS Foundation Trust, in Surrey. The SaNOtize Nitric Oxide Nasal Spray (NONS) is designed to kill the virus in the upper airways, preventing it…
BRISBANE: ImpediMed Limited announced a second contract valued at over $2.0 million for its SOZO Digital Health Platform to be used in a clinical trial being conducted for AstraZeneca, a global pharmaceutical company. The Phase II trial will use the SOZO devices to track patient fluid volume in an upcoming pharmaceutical study focused on chronic…
LONDON: AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites in and outside the US that are due to begin in the next weeks, a news release said. AstraZeneca has received support of around $486 million from the US Government for the development…